Vaccine: News
Moderna says its COVID-19 vaccine '100% effective' against severe cases
United States pharmaceutical company Moderna on Monday said that it will seek emergency approval for its COVID-19 vaccine in the US and Europe.
Pfizer, BioNTech say their COVID-19 vaccine is over 90% effective
United States pharmaceutical giant Pfizer and German biotech firm BioNTech have said their COVID-19 vaccine is over 90% effective, according to initial data from a large study.
COVAXIN: Doctors, nurses, MBBS students to get first vaccine doses
Health workers will be among the first 30 crore people to be administered Bharat Biotech's COVID-19 vaccine.
Oxford COVID-19 vaccine generates immune response among young and old
The COVID-19 vaccine being developed by Oxford University and AstraZeneca generates similar immune responses among younger and older adults, the pharmaceutical company has said.
Sputnik V Phase-II trials to have 100 volunteers: Dr. Reddy's
Phase II clinical trials for the Russian COVID-19 vaccine, Sputnik V, will have 100 volunteers, the Indian Central Drugs Standard Control Organisation's Drug Controller General (DCGI) has told Sputnik.
Coronavirus: Bharat Biotech aims to launch COVAXIN by June 2021
Hyderabad-based pharmaceutical firm Bharat Biotech is expecting to launch its coronavirus vaccine candidate, COVAXIN, by June next year.
Coronavirus: India reserves Rs. 50,000 crore for vaccinating entire country
The Indian government has reportedly set aside Rs. 50,000 crore to ensure that the COVID-19 vaccine reaches the entire country.
Lockdown has gone, but coronavirus has not: Modi addresses nation
Prime Minister Narendra Modi on Tuesday addressed the nation. Modi warned people against laxity ahead of the festive season, when experts have maintained that the number of fresh infections may rise once again.
India to play crucial role in COVID-19 vaccine process
As the world's largest vaccine manufacturer, India will play a major role in the vaccination efforts for COVID-19.
India may get COVID-19 vaccine by March 2021: SII official
India may get a vaccine for COVID-19 by March 2021, the Executive Director of the Serum Institute of India (SII) has said.
Coronavirus reinfections are possible, very rare, and significant
In the early stages of the coronavirus pandemic, there were talks of herd immunity with a significant portion of the population contracting the viral infection.
When will India get coronavirus vaccine? Early 2021, claims minister
Giving a glimmer of hope to a nation buried by coronavirus caseload and deaths linked to it, Union Health Minister Harsh Vardhan said today India will most likely get the vaccine by early 2021.
COVAXIN to Oxford: Coronavirus vaccine updates for India
Although the coronavirus outbreak in India has started to slow down, the country remains the second worst-hit in the world.
Coronavirus vaccine to reach 25 crore Indians by mid-2021: Government
The Indian government is planning to provide vaccines to roughly 25 crore people by July 2021, Union Health Minister Dr. Harsh Vardhan said on Sunday.
Coronavirus vaccine roll-out expected within 3 months in UK: Report
As the world awaits a vaccine against COVID-19, Oxford University's vaccine will reportedly be mass rolled-out within three months.
Over five lakh sharks could be killed for COVID-19 vaccine
While the entire world is looking forward to positive news about a COVID-19 vaccine, global vaccination could mean the death of half a million sharks, an advocacy group has warned.
Johnson & Johnson's single-dose COVID-19 vaccine induces strong immunity
Johnson & Johnson's COVID-19 vaccine has shown promise in early-to-mid-stage clinical human trials.
UK planning "challenge trials" that deliberately expose volunteers to COVID-19
With the world waiting for a coronavirus vaccine with bated breath, the United Kingdom is looking to launch an unusual trial — one wherein volunteers would be intentionally infected with the virus to judge how effective a vaccine is.
Johnson & Johnson's COVID-19 vaccine goes into final human trials
In a major development, American pharma giant Johnson & Johnson has launched the final trial of its COVID-19 vaccine.
Vaccine expected by early 2021; nationwide immunization a challenge: Scientist
A vaccine for COVID-19 is likely to be ready by early 2021, a leading vaccine scientist has said. However, the real challenge for India would be conducting a vaccination drive for its population of 1.3 billion.
COVID-19 vaccine: Serum Institute to start final trials this week
As India's COVID-19 cases continue to surge by nearly a lakh every passing day, scientists are racing to get a vaccine ready as soon as possible.
One in seven volunteers for Sputnik V report side effects
Sputnik V, the COVID-19 vaccine developed and approved by Russia, has shown side effects in some trial volunteers.
Not herd-immunity; vaccine critical for ending pandemic, says Bill Gates
Microsoft co-founder Bill Gates said that a vaccine for COVID-19 is critical and the herd immunity strategy cannot end the pandemic.
AstraZeneca resumes clinical trials for COVID-19 vaccine after UK nod
Late-stage clinical trials of a COVID-19 vaccine being developed by the drug firm AstraZeneca and the University of Oxford have resumed.
Coronavirus: Serum Institute ordered to halt recruitment for vaccine trial
The Drugs Controller General of India (DCGI) has ordered the Serum Institute of India (SII) to pause the recruitment of volunteers for Phase 2 and Phase 3 trials of the coronavirus vaccine, being developed by the University of Oxford and UK-pharma giant AstraZeneca.
China approves trial of new 'nasal spray vaccine' for COVID-19
In a major move, China's National Medical Products Administration has cleared a new 'nasal spray' COVID-19 vaccine for human trials.
Coronavirus: Australia leads race toward getting vaccinated, signs important deals
Australians might be the first ones to get protection from coronavirus, thanks to two deals that Prime Minister Scott Morrison has inked with those developing the vaccines.
Sputnik V phase 3 trials could be conducted in India
The Gamaleya Research Institute of Epidemiology and Microbiology in Russia has reportedly submitted "comprehensive data" on its COVID-19 vaccine candidate to Indian authorities.
Bangladesh's Beximco enters COVID-19 vaccine deal with India's Serum Institute
One of Bangladesh's largest drugmakers, Beximco Pharmaceuticals, has announced that it will invest in the Serum Institute of India (SII) for the development of a coronavirus vaccine.
HK man gets reinfected by coronavirus: What does it mean
A 33-year-old man in Hong Kong has contracted COVID-19 twice this year in what is said to be the first documented case of reinfection, according to preliminary research.
All you need to know about WHO's global COVAX initiative
With little hope that the coronavirus pandemic is going to slow down any time soon, all eyes are on the development of a vaccine against SARS-CoV-2.
China clears COVID-19 vaccines for emergency use: Details here
China has given emergency use authorization to select candidate vaccines developed to prevent COVID-19, the novel coronavirus disease that originated in the country.
Russia looking to partner with India for COVID-19 vaccine production
Russia has been in the headlines for its two-month-tested 'Sputnik V' COVID-19 vaccine.
India: Serum Institute's COVID-19 vaccine goes into Phase-2/3 trials
In a major development, Adar Poonawalla's Serum Institute of India has started the Phase-2/3 trial of a promising COVID-19 vaccine licensed from AstraZeneca and Oxford University.
Vipul Shah to make a web series on vaccine trials
Looks like, Bollywood is leaving no stone unturned in bringing alive the dystopian premise we're currently experiencing, onto the screen.
More infectious coronavirus strain with D614G mutation found in Malaysia
A strain of the novel coronavirus that is 10 times more infectious has been found in Malaysia. This specific strain has previously been seen in other parts of the world and is predominant in Europe and the United States.
Sputnik V: Russia's COVID-19 vaccine goes into production
Despite all the questions over safety and efficacy, Russia is moving ahead with what it claims is the first officially registered vaccine for COVID-19.
Pfizer's COVID-19 vaccine shows promise in human trials: Details here
The COVID-19 candidate vaccine jointly developed by American pharma giant Pfizer and German biotech company BioNTech has shown promise in early human trials.
Coronavirus: How soon could Russian vaccine be available in India?
On Tuesday, Russia announced what it claims is the first COVID-19 vaccine, developed by the Gamaleya Research Institute of Epidemiology and Microbiology in Moscow.
Indians are searching ways to MAKE coronavirus vaccine at home
The sporadic surge in the number of COVID-19 cases and deaths has made the whole world desperate for a vaccine.